Record $24.2m NPAT and 115.4% FCF conversion cut net debt to $20.4m

PBT rose 5.1% to $33.1m and operating profit 4.4% to $35.0m on a stable 27.0% effective tax rate — modest operating leverage on a flat top line. EBITDA was $43.2m, and FCF converted at 115.4% of NPAT, up from 70.2%. Gross borrowings declined from $55.0m to $39.0m.

Industrial division revenue rose to 69.8% of group from 65.7%, while Agri's share fell 3.8 pp to 30.6%. Capex remained light at 2.6% of revenue.

FCF of $27.9m on NPAT growth of only 5.2% funded the step-down in gross borrowings and a higher 9.0c interim dividend (73.0% of NPAT but just 63.3% of FCF). For a project-based industrial, this signals tight collections and capex discipline in H1.

Working-capital absorption is the offset. Operating working capital rose $6.9m, with inventory days extending from 88.5 to 94.5 and receivable days from 53.9 to 55.7. Management frames the inventory build as risk mitigation, but in a project-based business rising inventory ahead of demand creates cash drag risk if H2 sell-through underwhelms — and the build is happening even though revenue did not grow.

Segment mix has rotated toward lower-margin Industrial. Industrial revenue grew to 69.8% of group at a disclosed 19.4% gross margin, while Agri retreated to 30.6% at a materially higher 30.7% gross margin. The Industrial volume tailwind is carrying the top line, but the mix shift is a slight headwind to blended gross margin — the absence of revenue growth despite Industrial expansion underlines this.

Management positions the inventory build as deliberate risk mitigation, which is consistent with the project-based industrial frame where lumpy delivery cycles can warrant pre-positioning. Without supplied guidance or forward-work disclosure, the H2 read hinges on whether Industrial momentum sustains and whether the Agri rebound (management cites strong dairy rubberware demand on a weak prior period) continues. The release supports a conclusion that H1 earnings quality is solid, but it does not support a confident view of H2 trajectory.

The effective tax rate is unchanged at 27.0%, so there is no tax distortion masking operating performance, and PBT and NPAT growth are aligned (5.1% vs 5.2%) — there is no one-off layer in the bridge. FCF of $27.9m converted at 115.4% of NPAT, well above prior. Leverage at roughly 0.5x net debt/EBITDA leaves substantial capacity, and capex at 2.6% of revenue is not flattering cash through under-investment relative to recent history.

The principal quality caveat is working capital. The $6.9m absorption — driven by a six-day extension in inventory days — consumes cash that would otherwise compound the deleveraging. ROE softened to 10.6% from 11.0% as equity grew faster than NPAT, which is the natural consequence of debt repayment building book value. The 9.0c dividend is comfortably covered by FCF (63.3% payout vs FCF) but consumes 73.0% of NPAT, up from 68.1%; sustained higher payout depends on cash conversion holding through the inventory cycle.

This briefing cannot assess H2 phasing or full-year trajectory because no forward-work, order book, or stated guidance metrics were disclosed.